Grill, J., Massimino, M., Bouffet, E., Azizi, A. A., McCowage, G., Cañete, A., . . . Vassal, G. (2018). Phase II, open-label, randomized, multicenter trial (HERBY) of Bevacizumab in pediatric patients with newly diagnosed high-grade glioma. American Society of Clinical Oncology.
Chicago Style (17th ed.) CitationGrill, Jacques, et al. Phase II, Open-label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients with Newly Diagnosed High-grade Glioma. American Society of Clinical Oncology, 2018.
MLA (9th ed.) CitationGrill, Jacques, et al. Phase II, Open-label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients with Newly Diagnosed High-grade Glioma. American Society of Clinical Oncology, 2018.
Warning: These citations may not always be 100% accurate.